Tuesday, April 5, 2016

Targeting Tax Inversions After #PanamaPapers

Targeting of tax inversions, tactics for corporations to reduce their tax burdens legally, may prove to be a little more difficult after the Panama papers leak. Does everyone pay their taxes, or only those without the necessary 'connections' protect their interests. Goldman Sachs, an organization that seeded key personal in influential positions through global governance, suggests the latter.

Headline: New U.S. inversion rules threaten Pfizer-Allergan deal

WASHINGTON/NEW YORK (Reuters) - The U.S. Treasury Department took new steps on Monday to curb tax-avoiding corporate "inversions," with the pending $160 billion merger of Pfizer Inc and Allergan Plc seen as a potential casualty.

The changes, less than a year before President Barack Obama ends his term, follow sharp political criticism of Pfizer's and Allergan's merger, which would be the largest inversion deal ever. While the rules did not single out this deal, one of the provisions takes aim directly at it.



Market-driven money flow, trend, and intermarket analysis is provided by an Insights key.